Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Lu; Jianliang
Address:
Fishers, IN
No. of patents:
14
Patents:












Patent Number Title Of Patent Date Issued
8299061 Inhibitors of diacylglycerol acyltransferase October 30, 2012
This invention provides compounds of formula I: ##STR00001## or a pharmaceutically acceptable salt thereof; as well as a method for treating obesity, a method for treating diabetes, and a pharmaceutical composition.
8263772 MCH receptor antagonists September 11, 2012
The present invention relates to a melanin concentrating hormone antagonist compound of formula (1): wherein R.sup.1, R.sup.a, R.sup.b, R.sup.2, L.sup.1, R.sup.3, R.sup.4 and R.sup.5 are as defined, or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture of diaster
8101764 MCH receptor antagonists January 24, 2012
The present invention relates to a melanin concentrating hormone antagonist compound of formula (I): wherein R.sup.1, R.sup.a, R.sup.b, R.sup.2, L.sup.1, R.sup.3, R.sup.4 and R.sup.5 are as defined, or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture of diaster
7897789 Vitamin D receptor modulators March 1, 2011
The present invention relates to novel, non-secosteroidal, phenyl-benzothiophene compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1.alpha.,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
7772425 Vitamin D receptor modulators August 10, 2010
The present invention relates to novel, non-secosteroidal, diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1.alpha.,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
7750184 Vitamin D receptor modulators July 6, 2010
The present invention relates to novel, non-secosteroidal, sulfonate and sulfonamide functional diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1.alpha.,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease a
7612067 Imidazopyridazine compounds November 3, 2009
The present invention relates to novel substituted imidazo[1,2-b]pyridazine compounds of Formula (I): pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurolog
7601850 Phenyl-thiophene type vitamin D receptor modulators October 13, 2009
The present invention relates to novel, non-secosteroidal, phenyl-thiophene compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1.alpha.,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
7595345 Vitamin D receptor modulators September 29, 2009
The present invention relates to novel, non-secosteroidal, hydroxyl substituted, carbon-linked diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psor
7582775 Vitamin D receptor modulators September 1, 2009
The present invention relates to novel, non-secosteroidal, phenyl-benzothiophene compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1.alpha.,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
7579488 Vitamin D receptor modulators August 25, 2009
The present invention relates to novel, non-secosteroidal, phenyl-benzofuran compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1.alpha.,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
7566803 Vitamin D receptor modulators July 28, 2009
The present invention relates to novel, non-secosteroidal, diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1.alpha.,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
7557103 Imidazopyridazine compounds July 7, 2009
The present invention relates to novel substituted imidazo[1,2-b]pyridazine compounds of Formula (I) pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurologi
7468449 Phenyl-furan compounds as vitamin D receptor modulators December 23, 2008
The present invention relates to novel, non-secosteroidal, phenyl-furan compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1.alpha.,25dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.










 
 
  Recently Added Patents
Systems and methods for building axes, co-axes and paleo-geographic coordinates related to a stratified geological volume
Container
Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity
Lid for a container
Monofocal photographing lens assembly
Method and apparatus for belling plastic pipe
Visual model importation
  Randomly Featured Patents
Open end mutual fund securitization process
X-ray CT apparatus and image-taking method therefor
Corrugated plastic pipe coupling
Siderail support mechanism with oblong pivot slot
Combined toy wheel and hub
Cell searching method and apparatus in multi-carrier system
Non-offensive termination of a call detection of an answering machine
Obtaining caprolactam by cleaving oligomers of caprolactam
Watering system automatic additive dispenser
Active field polarized media air cleaner